BUILD-IN PAGE COMPOSER

Dr. Jeyaraj Vadiveloo University of Connecticut Director of the Janet and Mark L. Goldenson Center for Actuarial Research Dr. Jay Vadiveloo is Professor and Director of the Goldenson Center for Actuarial Research at the University of Connecticut. With over 30 years of experience in industry and academia, Dr. Vadiveloo now focuses on applied actuarial research projects from industry using teams of highly talented graduate students to come up with practical,

TRAVEL

BEAUTY

HIPSTER

Latest Posts

Allianz in January 2018 invested $59.2 million in Boston, Massachussets-headquartered U.S. telehealth platform American Well. Allianz carried out the investment through its digital investment unit, Allianz X, supported by the Health Innovation Center of Allianz Partners. Furthermore, Allianz will join American Well’s Board of Directors. American Well’s telehealth platform, called The Exchange, handles clinical, administration, and security requirements according to U.S. healthcare regulations and best practices. In addition to

CNA Hardy, a commercial insurer operating within the Lloyds market, in January 2018 appointed Stuart Middleton as CEO of its subsidiary in Luxembourg. The company had announced in June of 2017 that it would set up a subsidiary group in Luxembourg ahead of Brexit. Middleton joined CNA Hardy in October 2017 as head of small business, coming from leadership roles such as Chief Underwriting Officer for Europe at Hiscox,

James Reid in January 2018 was appointed Executive Vice President, Global Employee Benefits at MetLife, reporting to Michel Khalaf, president U.S. business and EMEA and a member of Met’s executive committee. In an exclusive interview, James discusses his plans with Global Benefits Vision. GBV: Should we start with the highlights of your career, focusing on employee benefits and international, that is global employee benefits including global mobility? James Reid:

Aviva, the UK’s largest general insurer and a leading life and pensions provider, in January 2018 announced its intention to withdraw from the international private medical insurance (iPMI) market, following a strategic review which found that iPMI “is not central” to the company’s focus on growing its health business in the UK. As of 1 May 2018, existing iPMI customers will be able to continue coverage by accepting a
SHARE

Sample Home 1